Meningococcal Vaccine Effective Against Serogroup B Meningococcal Vaccine Effective Against Serogroup B
The 4CMenB vaccine provides broad protection against serogroup B when given in 2 different schedules, either with or separately from routine vaccinations. Medscape Medical News (Source: Medscape Today Headlines)
FDA questions Amgen drug for prostate cancer
The FDA will ask a panel of outside experts whether the benefits of Amgen's Xgeva outweigh its risks, which included bone disease. (Source: USATODAY.com Health)